GUFICBIO

Gufic BioSciences Share Price

₹467.75 +2.3 (0.49%)

05 Nov, 2024 17:23

SIP TrendupStart SIP in GUFICBIO

Start SIP

Performance

  • Low
  • ₹457
  • High
  • ₹480
  • 52 Week Low
  • ₹260
  • 52 Week High
  • ₹480
  • Open Price₹469
  • Previous Close₹465
  • Volume347,799

Investment Returns

  • Over 1 Month + 23.16%
  • Over 3 Month + 34.33%
  • Over 6 Month + 45.17%
  • Over 1 Year + 72.86%
SIP Lightning

Smart Investing Starts Here Start SIP with Gufic BioSciences for Steady Growth!

Gufic BioSciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 54.3
  • PEG Ratio
  • Market Cap Cr
  • 4,691
  • P/B Ratio
  • 8.8
  • Average True Range
  • 20.42
  • EPS
  • 8.8
  • Dividend Yield
  • 0
  • MACD Signal
  • 11.19
  • RSI
  • 68.19
  • MFI
  • 66.28

Gufic BioSciences Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations202.81194.99201.78214.87195.02
Total Income From Operations202.81194.99201.78214.87195.02
P/L Before Interest, Excpt. Items & Tax32.7330.7732.7435.4132.12
P/L Before Exceptional Items & Tax28.1127.1229.5630.9528.05
P/L After Tax from Ordinary Activities20.8620.0522.2623.2120.62
Net Profit/Loss For the Period20.8620.0522.2623.2120.62
IndicatorMar 24Mar 23
Revenue From Operations [Gross]769.66679.75
Revenue From Operations [Net]769.66679.75
Total Operating Revenues806.67690.62
Total Revenue808.84693.19
Total Expenses693.17586.47
Profit/Loss Before Tax115.67106.72
Profit/Loss For The Period86.1479.70
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity-7.46-26.59
Net Cash Used In Investing Activity-102.40-190.73
Net Cash Used in Finance Activity82.38234.31
Net Inc/Dec In Cash And Equivalent-27.4816.99
Cash And Equivalent End Of Year1.1328.60
IndicatorMar 24Mar 23
Total Share Capital10.039.69
Total Non-Current Liabilities187.93225.14
Total Current Liabilities372.05288.21
Total Capital And Liabilities1,092.54861.16
Total Non-Current Assets492.07397.05
Total Current Assets600.47464.11
Total Assets1,092.54861.16
Indicator20242023
EBIT Margin (%)16.2416.64
Return On Capital Employed (%)18.1820.06
Return On Equity (%)16.1722.91
Long Term Debt To Equity (%)28.9054.82
Book Value/Share (INR)53.1135.88
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations202.81194.99201.78214.87195.02
Total Income From Operations202.81194.99201.78214.87195.02
P/L Before Interest, Excpt. Items & Tax32.7330.7732.7435.4132.12
P/L Before Exceptional Items & Tax28.1027.1229.5630.9528.05
P/L After Tax from Ordinary Activities20.8620.0522.2623.2120.62
Net Profit/Loss For the Period20.8620.0522.2623.2120.62
IndicatorMar 24
Revenue From Operations [Gross]769.66
Revenue From Operations [Net]769.66
Total Operating Revenues806.67
Total Revenue808.84
Total Expenses693.17
Profit/Loss Before Tax115.67
Profit/Loss For The Period86.14
IndicatorMar 24
Net CashFlow - Operating Activity-7.46
Net Cash Used In Investing Activity-102.39
Net Cash Used in Finance Activity82.38
Net Inc/Dec In Cash And Equivalent-27.47
Cash And Equivalent End Of Year1.14
IndicatorMar 24
Total Share Capital10.03
Total Non-Current Liabilities187.93
Total Current Liabilities372.05
Total Capital And Liabilities1,092.54
Total Non-Current Assets492.06
Total Current Assets600.48
Total Assets1,092.54
Indicator20242023
EBIT Margin (%)16.2416.64
Return On Capital Employed (%)18.1820.06
Return On Equity (%)16.1722.91
Long Term Debt To Equity (%)28.9054.82
Book Value/Share (INR)53.1135.88

Gufic BioSciences Technicals

EMA & SMA

Current Price
₹467.75
+ 2.3 (0.49%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹427.25
  • 50 Day
  • ₹407.38
  • 100 Day
  • ₹385.95
  • 200 Day
  • ₹357.36

Resistance and Support

457.75 Pivot Speed
  • R3 523.70
  • R2 499.15
  • R1 482.30
  • S1 440.90
  • S2 416.35
  • S3 399.50

Is Gufic BioSciences Worth Buying?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Gufic Biosciences Ltd. is a leading Indian biopharmaceutical company specializing in the development and manufacturing of high-quality pharmaceuticals, including injectables, oncology products, and active pharmaceutical ingredients (APIs). The company focuses on innovation, quality, and patient care in its offerings. Gufic Biosciences has an operating revenue of Rs. 814.46 Cr. on a trailing 12-month basis. An annual revenue growth of 17% is outstanding, Pre-tax margin of 14% is healthy, ROE of 16% is good. The company has a reasonable debt to equity of 29%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 25% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 77 which is a FAIR score but needs to improve its earnings, a RS Rating of 79 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 32 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Gufic BioSciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-08-14 Quarterly Results
2024-05-29 Audited Results & Final Dividend
2024-02-14 Quarterly Results
2023-11-09 Quarterly Results
2023-08-11 Quarterly Results & ESOP

Gufic BioSciences F&O

Gufic BioSciences Shareholding Pattern

72.51%
2.51%
0.23%
16.01%
8.74%
  • NSE Symbol
  • GUFICBIO
  • BSE Symbol
  • 509079
  • Chairman & Managing Director
  • Mr. Jayesh P Choksi
  • ISIN
  • INE742B01025

Gufic BioSciences FAQs

Gufic BioSciences share price is ₹467 As on 05 November, 2024 | 17:09

The Market Cap of Gufic BioSciences is ₹4690.5 Cr As on 05 November, 2024 | 17:09

The P/E ratio of Gufic BioSciences is 54.3 As on 05 November, 2024 | 17:09

The PB ratio of Gufic BioSciences is 8.8 As on 05 November, 2024 | 17:09

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form